Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for GTS-21

See Plans and Pricing

« Back to Dashboard

Drug Development Status for GTS-21: Patents, clinical trial progress, indications

GTS-21 is an investigational drug.

There have been 8 clinical trials for GTS-21. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2006.

The most common disease conditions in clinical trials are Tourette Syndrome, Syndrome, and Schizophrenia. The leading clinical trial sponsors are CoMentis, VA Office of Research and Development, and Radboud University.

Recent Clinical Trials for GTS-21
Selective Microbiota Transplantation for Tourette's SyndromeFaming ZhangPhase 1/Phase 2
Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's DisorderChina Medical University HospitalPhase 2
Effects of GTS-21 on Smoking Behavior and Neurocognitive FunctionsUniversity of FloridaPhase 2

See all GTS-21 clinical trials

Clinical Trial Summary for GTS-21

Top disease conditions for GTS-21
Top clinical trial sponsors for GTS-21

See all GTS-21 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.